EV Cables
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Glucagon Injectable Market Research Report 2023
1 Glucagon Injectable Market Overview
1.1 Product Overview and Scope of Glucagon Injectable
1.2 Glucagon Injectable Segment by Age
1.2.1 Global Glucagon Injectable Sales Growth Rate Comparison by Age (2022-2028)
1.2.2 Children
1.2.3 Adults
1.3 Glucagon Injectable Segment by Distribution Channel
1.3.1 Global Glucagon Injectable Sales Comparison by Distribution Channel: (2022-2028)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Glucagon Injectable Market Size Estimates and Forecasts
1.4.1 Global Glucagon Injectable Revenue 2017-2028
1.4.2 Global Glucagon Injectable Sales 2017-2028
1.4.3 Glucagon Injectable Market Size by Region: 2017 Versus 2021 Versus 2028
2 Glucagon Injectable Market Competition by Manufacturers
2.1 Global Glucagon Injectable Sales Market Share by Manufacturers (2017-2022)
2.2 Global Glucagon Injectable Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Glucagon Injectable Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Glucagon Injectable Manufacturing Sites, Area Served, Product Type
2.5 Glucagon Injectable Market Competitive Situation and Trends
2.5.1 Glucagon Injectable Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Glucagon Injectable Players Market Share by Revenue
2.5.3 Global Glucagon Injectable Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucagon Injectable Retrospective Market Scenario by Region
3.1 Global Glucagon Injectable Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Glucagon Injectable Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Glucagon Injectable Market Facts & Figures by Country
3.3.1 North America Glucagon Injectable Sales by Country
3.3.2 North America Glucagon Injectable Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Glucagon Injectable Market Facts & Figures by Country
3.4.1 Europe Glucagon Injectable Sales by Country
3.4.2 Europe Glucagon Injectable Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Glucagon Injectable Market Facts & Figures by Region
3.5.1 Asia Pacific Glucagon Injectable Sales by Region
3.5.2 Asia Pacific Glucagon Injectable Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Glucagon Injectable Market Facts & Figures by Country
3.6.1 Latin America Glucagon Injectable Sales by Country
3.6.2 Latin America Glucagon Injectable Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Glucagon Injectable Market Facts & Figures by Country
3.7.1 Middle East and Africa Glucagon Injectable Sales by Country
3.7.2 Middle East and Africa Glucagon Injectable Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Glucagon Injectable Historic Market Analysis by Age
4.1 Global Glucagon Injectable Sales Market Share by Age (2017-2022)
4.2 Global Glucagon Injectable Revenue Market Share by Age (2017-2022)
4.3 Global Glucagon Injectable Price by Age (2017-2022)
5 Global Glucagon Injectable Historic Market Analysis by Distribution Channel
5.1 Global Glucagon Injectable Sales Market Share by Distribution Channel (2017-2022)
5.2 Global Glucagon Injectable Revenue Market Share by Distribution Channel (2017-2022)
5.3 Global Glucagon Injectable Price by Distribution Channel (2017-2022)
6 Key Companies Profiled
6.1 Fresenius SE & Co. KGaA
6.1.1 Fresenius SE & Co. KGaA Corporation Information
6.1.2 Fresenius SE & Co. KGaA Description and Business Overview
6.1.3 Fresenius SE & Co. KGaA Glucagon Injectable Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Fresenius SE & Co. KGaA Glucagon Injectable Product Portfolio
6.1.5 Fresenius SE & Co. KGaA Recent Developments/Updates
6.2 Xeris Pharmaceuticals Inc
6.2.1 Xeris Pharmaceuticals Inc Corporation Information
6.2.2 Xeris Pharmaceuticals Inc Description and Business Overview
6.2.3 Xeris Pharmaceuticals Inc Glucagon Injectable Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Xeris Pharmaceuticals Inc Glucagon Injectable Product Portfolio
6.2.5 Xeris Pharmaceuticals Inc Recent Developments/Updates
6.3 Novo Nordisk A/S
6.3.1 Novo Nordisk A/S Corporation Information
6.3.2 Novo Nordisk A/S Description and Business Overview
6.3.3 Novo Nordisk A/S Glucagon Injectable Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Novo Nordisk A/S Glucagon Injectable Product Portfolio
6.3.5 Novo Nordisk A/S Recent Developments/Updates
6.4 ILS.Inc
6.4.1 ILS.Inc Corporation Information
6.4.2 ILS.Inc Description and Business Overview
6.4.3 ILS.Inc Glucagon Injectable Sales, Revenue and Gross Margin (2017-2022)
6.4.4 ILS.Inc Glucagon Injectable Product Portfolio
6.4.5 ILS.Inc Recent Developments/Updates
6.5 Amphastar Pharmaceuticals Inc.
6.5.1 Amphastar Pharmaceuticals Inc. Corporation Information
6.5.2 Amphastar Pharmaceuticals Inc. Description and Business Overview
6.5.3 Amphastar Pharmaceuticals Inc. Glucagon Injectable Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Amphastar Pharmaceuticals Inc. Glucagon Injectable Product Portfolio
6.5.5 Amphastar Pharmaceuticals Inc. Recent Developments/Updates
6.6 Lilly USA, LLC
6.6.1 Lilly USA, LLC Corporation Information
6.6.2 Lilly USA, LLC Description and Business Overview
6.6.3 Lilly USA, LLC Glucagon Injectable Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Lilly USA, LLC Glucagon Injectable Product Portfolio
6.6.5 Lilly USA, LLC Recent Developments/Updates
6.7 Zealand Pharma A/S.
6.6.1 Zealand Pharma A/S. Corporation Information
6.6.2 Zealand Pharma A/S. Description and Business Overview
6.6.3 Zealand Pharma A/S. Glucagon Injectable Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Zealand Pharma A/S. Glucagon Injectable Product Portfolio
6.7.5 Zealand Pharma A/S. Recent Developments/Updates
6.8 Avalon Pharma Pvt. Ltd.
6.8.1 Avalon Pharma Pvt. Ltd. Corporation Information
6.8.2 Avalon Pharma Pvt. Ltd. Description and Business Overview
6.8.3 Avalon Pharma Pvt. Ltd. Glucagon Injectable Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Avalon Pharma Pvt. Ltd. Glucagon Injectable Product Portfolio
6.8.5 Avalon Pharma Pvt. Ltd. Recent Developments/Updates
7 Glucagon Injectable Manufacturing Cost Analysis
7.1 Glucagon Injectable Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Glucagon Injectable
7.4 Glucagon Injectable Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Glucagon Injectable Distributors List
8.3 Glucagon Injectable Customers
9 Glucagon Injectable Market Dynamics
9.1 Glucagon Injectable Industry Trends
9.2 Glucagon Injectable Market Drivers
9.3 Glucagon Injectable Market Challenges
9.4 Glucagon Injectable Market Restraints
10 Global Market Forecast
10.1 Glucagon Injectable Market Estimates and Projections by Age
10.1.1 Global Forecasted Sales of Glucagon Injectable by Age (2023-2028)
10.1.2 Global Forecasted Revenue of Glucagon Injectable by Age (2023-2028)
10.2 Glucagon Injectable Market Estimates and Projections by Distribution Channel
10.2.1 Global Forecasted Sales of Glucagon Injectable by Distribution Channel (2023-2028)
10.2.2 Global Forecasted Revenue of Glucagon Injectable by Distribution Channel (2023-2028)
10.3 Glucagon Injectable Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Glucagon Injectable by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Glucagon Injectable by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Glucagon Injectable Sales Growth Rate Comparison by Age (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Glucagon Injectable Sales Growth Rate Comparison by Distribution Channel (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Glucagon Injectable Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Glucagon Injectable Market Competitive Situation by Manufacturers in 2021
Table 5. Global Glucagon Injectable Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Glucagon Injectable Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Glucagon Injectable Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Glucagon Injectable Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Glucagon Injectable Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Glucagon Injectable Manufacturing Sites and Area Served
Table 11. Manufacturers Glucagon Injectable Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Glucagon Injectable by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon Injectable as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Glucagon Injectable Sales by Region (2017-2022) & (K Units)
Table 16. Global Glucagon Injectable Sales Market Share by Region (2017-2022)
Table 17. Global Glucagon Injectable Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Glucagon Injectable Revenue Market Share by Region (2017-2022)
Table 19. North America Glucagon Injectable Sales by Country (2017-2022) & (K Units)
Table 20. North America Glucagon Injectable Sales Market Share by Country (2017-2022)
Table 21. North America Glucagon Injectable Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Glucagon Injectable Revenue Market Share by Country (2017-2022)
Table 23. Europe Glucagon Injectable Sales by Country (2017-2022) & (K Units)
Table 24. Europe Glucagon Injectable Sales Market Share by Country (2017-2022)
Table 25. Europe Glucagon Injectable Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Glucagon Injectable Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Glucagon Injectable Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Glucagon Injectable Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Glucagon Injectable Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Glucagon Injectable Revenue Market Share by Region (2017-2022)
Table 31. Latin America Glucagon Injectable Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Glucagon Injectable Sales Market Share by Country (2017-2022)
Table 33. Latin America Glucagon Injectable Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Glucagon Injectable Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Glucagon Injectable Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Glucagon Injectable Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Glucagon Injectable Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Glucagon Injectable Revenue Market Share by Country (2017-2022)
Table 39. Global Glucagon Injectable Sales by Age (2017-2022) & (K Units)
Table 40. Global Glucagon Injectable Sales Market Share by Age (2017-2022)
Table 41. Global Glucagon Injectable Revenue by Age (2017-2022) & (US$ Million)
Table 42. Global Glucagon Injectable Revenue Share by Age (2017-2022)
Table 43. Global Glucagon Injectable Price by Age (2017-2022) & (US$/Unit)
Table 44. Global Glucagon Injectable Sales (K Units) by Distribution Channel (2017-2022)
Table 45. Global Glucagon Injectable Sales Market Share by Distribution Channel (2017-2022)
Table 46. Global Glucagon Injectable Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 47. Global Glucagon Injectable Revenue Share by Distribution Channel (2017-2022)
Table 48. Global Glucagon Injectable Price by Distribution Channel (2017-2022) & (US$/Unit)
Table 49. Fresenius SE & Co. KGaA Corporation Information
Table 50. Fresenius SE & Co. KGaA Description and Business Overview
Table 51. Fresenius SE & Co. KGaA Glucagon Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Fresenius SE & Co. KGaA Glucagon Injectable Product
Table 53. Fresenius SE & Co. KGaA Recent Developments/Updates
Table 54. Xeris Pharmaceuticals Inc Corporation Information
Table 55. Xeris Pharmaceuticals Inc Description and Business Overview
Table 56. Xeris Pharmaceuticals Inc Glucagon Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Xeris Pharmaceuticals Inc Glucagon Injectable Product
Table 58. Xeris Pharmaceuticals Inc Recent Developments/Updates
Table 59. Novo Nordisk A/S Corporation Information
Table 60. Novo Nordisk A/S Description and Business Overview
Table 61. Novo Nordisk A/S Glucagon Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Novo Nordisk A/S Glucagon Injectable Product
Table 63. Novo Nordisk A/S Recent Developments/Updates
Table 64. ILS.Inc Corporation Information
Table 65. ILS.Inc Description and Business Overview
Table 66. ILS.Inc Glucagon Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. ILS.Inc Glucagon Injectable Product
Table 68. ILS.Inc Recent Developments/Updates
Table 69. Amphastar Pharmaceuticals Inc. Corporation Information
Table 70. Amphastar Pharmaceuticals Inc. Description and Business Overview
Table 71. Amphastar Pharmaceuticals Inc. Glucagon Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Amphastar Pharmaceuticals Inc. Glucagon Injectable Product
Table 73. Amphastar Pharmaceuticals Inc. Recent Developments/Updates
Table 74. Lilly USA, LLC Corporation Information
Table 75. Lilly USA, LLC Description and Business Overview
Table 76. Lilly USA, LLC Glucagon Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Lilly USA, LLC Glucagon Injectable Product
Table 78. Lilly USA, LLC Recent Developments/Updates
Table 79. Zealand Pharma A/S. Corporation Information
Table 80. Zealand Pharma A/S. Description and Business Overview
Table 81. Zealand Pharma A/S. Glucagon Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Zealand Pharma A/S. Glucagon Injectable Product
Table 83. Zealand Pharma A/S. Recent Developments/Updates
Table 84. Avalon Pharma Pvt. Ltd. Corporation Information
Table 85. Avalon Pharma Pvt. Ltd. Description and Business Overview
Table 86. Avalon Pharma Pvt. Ltd. Glucagon Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Avalon Pharma Pvt. Ltd. Glucagon Injectable Product
Table 88. Avalon Pharma Pvt. Ltd. Recent Developments/Updates
Table 89. Production Base and Market Concentration Rate of Raw Material
Table 90. Key Suppliers of Raw Materials
Table 91. Glucagon Injectable Distributors List
Table 92. Glucagon Injectable Customers List
Table 93. Glucagon Injectable Market Trends
Table 94. Glucagon Injectable Market Drivers
Table 95. Glucagon Injectable Market Challenges
Table 96. Glucagon Injectable Market Restraints
Table 97. Global Glucagon Injectable Sales Forecast by Age (2023-2028) & (K Units)
Table 98. Global Glucagon Injectable Sales Market Share Forecast by Age (2023-2028)
Table 99. Global Glucagon Injectable Revenue Forecast by Age (2023-2028) & (US$ Million)
Table 100. Global Glucagon Injectable Revenue Market Share Forecast by Age (2023-2028)
Table 101. Global Glucagon Injectable Sales Forecast by Distribution Channel (2023-2028) & (K Units)
Table 102. Global Glucagon Injectable Sales Market Share Forecast by Distribution Channel (2023-2028)
Table 103. Global Glucagon Injectable Revenue Forecast by Distribution Channel (2023-2028) & (US$ Million)
Table 104. Global Glucagon Injectable Revenue Market Share Forecast by Distribution Channel (2023-2028)
Table 105. Global Glucagon Injectable Sales Forecast by Region (2023-2028) & (K Units)
Table 106. Global Glucagon Injectable Sales Market Share Forecast by Region (2023-2028)
Table 107. Global Glucagon Injectable Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 108. Global Glucagon Injectable Revenue Market Share Forecast by Region (2023-2028)
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glucagon Injectable
Figure 2. Global Glucagon Injectable Market Share by Age in 2021 & 2028
Figure 3. Children Product Picture
Figure 4. Adults Product Picture
Figure 5. Global Glucagon Injectable Market Share by Distribution Channel in 2021 & 2028
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Others
Figure 10. Global Glucagon Injectable Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Glucagon Injectable Market Size (2017-2028) & (US$ Million)
Figure 12. Global Glucagon Injectable Sales (2017-2028) & (K Units)
Figure 13. Glucagon Injectable Sales Share by Manufacturers in 2021
Figure 14. Global Glucagon Injectable Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Glucagon Injectable Players: Market Share by Revenue in 2021
Figure 16. Glucagon Injectable Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Glucagon Injectable Sales Market Share by Region (2017-2022)
Figure 18. Global Glucagon Injectable Sales Market Share by Region in 2021
Figure 19. Global Glucagon Injectable Revenue Market Share by Region (2017-2022)
Figure 20. Global Glucagon Injectable Revenue Market Share by Region in 2021
Figure 21. U.S. Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Glucagon Injectable Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Glucagon Injectable by Age (2017-2022)
Figure 46. Manufacturing Cost Structure of Glucagon Injectable
Figure 47. Manufacturing Process Analysis of Glucagon Injectable
Figure 48. Glucagon Injectable Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Fresenius SE & Co. KGaA Xeris Pharmaceuticals Inc Novo Nordisk A/S ILS.Inc Amphastar Pharmaceuticals Inc. Lilly USA, LLC Zealand Pharma A/S. Avalon Pharma Pvt. Ltd.